SPRB
SPRB
NASDAQ · Biotechnology

Spruce Biosciences Inc

$72.40
+1.55 (+2.19%)
As of Feb 8, 2:15 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 53.02M 47.19M 56.70M
Net Income 1.91M 1.39M 1.91M
EPS
Profit Margin 3.6% 2.9% 3.4%
Rev Growth +15.8% -2.9% 0.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 23.56M 23.83M 28.52M
Total Equity 50.79M 49.45M 51.98M
D/E Ratio 0.46 0.48 0.55
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 2.67M 2.51M 2.71M
Free Cash Flow 1.24M 802.3K 1.02M